Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/13/2025

Hospitalization Criteria for Hepatitis

Immediate Hospitalization Criteria

  • The American Association for the Study of Liver Diseases recommends hospitalization for patients with acute liver failure (ALF), defined as coagulation abnormality (INR ≥1.5) and any degree of mental alteration (encephalopathy) in a patient without preexisting cirrhosis and with illness duration of ≤26 weeks 1
  • Patients with altered mental status/encephalopathy and prolonged prothrombin time (INR ≥1.5) require immediate hospital admission and transfer to intensive care unit 1
  • The American Association for the Study of Liver Diseases recommends immediate hospitalization for patients with severe nausea and vomiting preventing oral intake in acute hepatitis patients 2
  • Patients with INR >1.5 or any signs of acute liver failure (e.g., hepatic encephalopathy) require immediate referral to a liver specialist 2
  • The American Gastroenterological Association recommends hospitalization for patients with Grade 4 immune checkpoint inhibitor (ICI) hepatitis with AST/ALT >20× upper limit of normal (ULN) or total bilirubin >10× ULN or hepatic decompensation (ascites, encephalopathy) 3

Additional Hospitalization Indications

  • The American College of Gastroenterology recommends hospitalization for patients with severe alcoholic hepatitis with Maddrey discriminant function >32 or MELD score >20 4
  • Patients with inadequate social and medical support in patients with alcoholic hepatitis and jaundice require hospitalization 4
  • The American College of Gastroenterology recommends hospitalization for patients with multi-organ failure (MOF) development, often due to infections after initial diagnosis of alcoholic hepatitis 4
  • Patients with acute kidney injury (AKI) as an early manifestation of MOF in hepatitis patients require hospitalization 4
  • The American Gastroenterological Association recommends hospitalization for patients with severe immune-mediated hepatitis (Grade 3-4) requiring high-dose glucocorticoid therapy and close monitoring 3, 5

Clinical and Laboratory Parameters to Monitor

  • The American Association for the Study of Liver Diseases recommends mental status assessment for subtle changes in mentation that may indicate developing encephalopathy 1
  • Prothrombin time/INR is a critical parameter for determining severity and need for hospitalization 1
  • The American Association for the Study of Liver Diseases recommends monitoring liver chemistries including AST, ALT, alkaline phosphatase, total bilirubin 1, 5
  • Arterial blood gases and lactate levels should be assessed to evaluate metabolic derangements 1
  • A complete blood count should be performed to evaluate for infection or bleeding complications 1
  • Renal function tests (creatinine, BUN) should be assessed to evaluate for hepatorenal syndrome 1

Management Principles After Hospitalization

  • The American Association for the Study of Liver Diseases recommends early contact with a transplant center for patients with ALF 6
  • Systematic administration of N-acetylcysteine is recommended for appropriate cases 6
  • Empirical broad-spectrum antibiotics should be administered for signs of sepsis or worsening encephalopathy 6
  • The American Gastroenterological Association recommends high-dose glucocorticoids (1-2 mg/kg methylprednisolone or equivalent) for severe immune-mediated hepatitis 3, 5
  • The American College of Gastroenterology recommends avoidance of nephrotoxic drugs including diuretics in patients with alcoholic hepatitis 4